JPH0217173A - Production of vitamin a or carboxylic acid ester thereof - Google Patents
Production of vitamin a or carboxylic acid ester thereofInfo
- Publication number
- JPH0217173A JPH0217173A JP16819188A JP16819188A JPH0217173A JP H0217173 A JPH0217173 A JP H0217173A JP 16819188 A JP16819188 A JP 16819188A JP 16819188 A JP16819188 A JP 16819188A JP H0217173 A JPH0217173 A JP H0217173A
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- group
- formula
- acid ester
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940045997 vitamin a Drugs 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 125000003262 carboxylic acid ester group Chemical class [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 title claims 3
- 150000004370 vitamin A ester derivatives Chemical class 0.000 title 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 23
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 23
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 23
- 239000011719 vitamin A Substances 0.000 claims abstract description 23
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 22
- 239000002904 solvent Substances 0.000 claims abstract description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical group OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 125000005843 halogen group Chemical group 0.000 claims abstract description 7
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 6
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 6
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 6
- 125000004423 acyloxy group Chemical group 0.000 claims abstract description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 5
- 150000003983 crown ethers Chemical class 0.000 claims abstract description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 4
- 239000000126 substance Substances 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 abstract description 18
- -1 halo sulfone Chemical class 0.000 abstract description 17
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 abstract description 11
- 229960000342 retinol acetate Drugs 0.000 abstract description 8
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 abstract description 8
- 235000019173 retinyl acetate Nutrition 0.000 abstract description 8
- 239000011770 retinyl acetate Substances 0.000 abstract description 8
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract description 4
- 150000001733 carboxylic acid esters Chemical class 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 239000011261 inert gas Substances 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- XQQZRZQVBFHBHL-UHFFFAOYSA-N 12-crown-4 Chemical compound C1COCCOCCOCCO1 XQQZRZQVBFHBHL-UHFFFAOYSA-N 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- 239000003674 animal food additive Substances 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 18
- 239000012044 organic layer Substances 0.000 description 18
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical class CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 5
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 150000003512 tertiary amines Chemical class 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical class CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JZOMOBUGVZDCPA-QFXXITGJSA-N (2e,6e)-nona-2,6-diene Chemical compound CC\C=C\CC\C=C\C JZOMOBUGVZDCPA-QFXXITGJSA-N 0.000 description 1
- HJDZTDLMEBIHJJ-ZIRGRKGMSA-N (3E,5E)-nona-1,3,5-triene Chemical compound CCC\C=C\C=C\C=C HJDZTDLMEBIHJJ-ZIRGRKGMSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical class CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はビタミンA又はそのカルがン酸エステルの製造
方法に関する。ビタミンA及びそのアセテート、ツクル
ミテートに代表されるカルボン酸エステルは医薬、飼l
I+添加剤などとして多量に使用されている。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for producing vitamin A or its carcinic acid ester. Vitamin A and its carboxylic acid esters such as acetate and tukulumitate are used in pharmaceuticals and livestock.
It is used in large quantities as an I+ additive.
従来、ビタミン人を製造する方法として特開昭62−8
7561号公報に記載のごとくハロスルホ/を炭化水素
系溶媒中、塩基で処理してビタミンAを製造する方法が
知られている。Conventionally, as a method for manufacturing vitamins, Japanese Patent Application Laid-open No. 62-8
As described in Japanese Patent No. 7561, a method for producing vitamin A by treating halosulfo/ with a base in a hydrocarbon solvent is known.
ノヘロスルホ/
〔発明が解決しようとする課題〕
上記従来の方法にしたがえば、反応原料であるハロスル
ホンをカリウムアルコキシドで処理した場合に比較的良
好な収率でビタミン人を得ることができるが、カリウム
アルコキシドは入手の容易さ、価格面などの点で問題が
あり、′−!たこの方法は反応底積で必ずしも満足でき
るものではなく。Noherosulfone/ [Problems to be Solved by the Invention] According to the conventional method described above, when the reaction raw material halosulfone is treated with potassium alkoxide, vitamin C can be obtained in a relatively good yield. Alkoxides have problems in terms of availability, price, etc. This method is not necessarily satisfactory in terms of reaction volume.
なお改善の余地がある。However, there is room for improvement.
しかして、本発明の目的は工業的に汎用でしかも安価な
塩基を使用しで、ビタミンAを好成績で製造する方法を
提供するにある。Therefore, an object of the present invention is to provide a method for producing vitamin A with good results using an industrially versatile and inexpensive base.
本発明によれば、上記の目的は、一般式(1)(式中、
R+Fi置換されていてもよいフェニル基を衣わし、X
lはハロゲン原子を表わす〕で示されるハロスルホンお
よび/または一般式(2)(式中、Rは前記定義のとお
りである)で示されるビニルスルホンを炭化水素系溶媒
中、一般式(3)
(式中、R2,R5,R’およびRは同一または異なり
それぞれアルキル基もしくはアラルキル基でアリ、Xは
ハロゲン原子、低級アルコキシ基、アシルオキシ基、硫
酸水素基又は水酸基を表わす)で示される第4級アンモ
ニウム塩又はクラウンエーテルの存在下水酸化カリウム
で処理し、必要に応じて生成するビタミンAをアシル化
することにより達成される。According to the present invention, the above object is achieved by the general formula (1) (wherein,
R+Fi optionally substituted phenyl group, X
l represents a halogen atom] and/or a vinyl sulfone represented by the general formula (2) (wherein R is as defined above) in a hydrocarbon solvent, the general formula (3) ( In the formula, R2, R5, R' and R are the same or different, each being an alkyl group or an aralkyl group, and X is a halogen atom, a lower alkoxy group, an acyloxy group, a hydrogen sulfate group or a hydroxyl group). This is achieved by treatment with potassium hydroxide in the presence of an ammonium salt or crown ether, and optionally acylating the produced vitamin A.
上記の一般式中におけるR’ 、 Xl、 R2,R’
R4、R5およびXを詳しく説明する。R1は置換され
ていてもよいフェニル基を表わし、ここで置換基として
はメチル、エチル、j−プロピル、n−プロピル、l−
ブチル、n−ブチルなどの低級アルキル基;塩素、臭素
、ヨウ素などのハロゲン原子;及びメトキシ、エトキシ
、l−プロポキシ、n−プロポキシ、l−ブトキシ、n
−ブトキシなどの低級アルコキシ基が例示される。また
、置換基はオルト位、メタ位又はノ4う位のいずれの位
置にあってもよく、1個又は2個以上の複数個であって
もよい、、Xは塩素原子、臭素原子、ヨウ素原子などの
ハロゲン原子を表わす。R', Xl, R2, R' in the above general formula
R4, R5 and X will be explained in detail. R1 represents an optionally substituted phenyl group, where the substituents include methyl, ethyl, j-propyl, n-propyl, l-
Lower alkyl groups such as butyl and n-butyl; halogen atoms such as chlorine, bromine, and iodine; and methoxy, ethoxy, l-propoxy, n-propoxy, l-butoxy, n
Examples include lower alkoxy groups such as -butoxy. In addition, the substituent may be located at any of the ortho-position, meta-position, or 4-position, and may be one or two or more substituents. X is a chlorine atom, a bromine atom, or an iodine atom. Represents a halogen atom such as an atom.
R、R、RおよびRはアルキル基又はアラルキル基を表
わす。ここで、アルキル基としては直鎖状もしくは分岐
状の炭素数1〜20のものが好適であり、メチル基、エ
チル基、れ−グロピル基、l−プロピル基、n−ブチル
基、ペンチル基。R, R, R and R represent an alkyl group or an aralkyl group. Here, the alkyl group is preferably a linear or branched one having 1 to 20 carbon atoms, such as a methyl group, an ethyl group, a chloropyl group, a l-propyl group, an n-butyl group, and a pentyl group.
ヘキシル基、ヘプチル基、オクチル基、ノニル基、デシ
ル基、ドデシル基、トリデシル基、オクタデシル基、ノ
ナデシル基などが例示される。またアラルキル基トシて
はベンジル基、1−フェニルエチル基、2−フェニルエ
チル基、3−フェニルゾロピル基などが例示される。X
はノ・ログン原子、低級アルコキシ基、アシルオキシ基
、硫酸水素基(H3O4−)又は水酸基を表わし、ノ〜
ロrン原子としては塩素、臭素、ヨウ素などが例示され
、低級アルコキシ基としてはメトキシ基、エトキシ基、
プロポキシ基、n−ブトキシ基、t−ブトキシ基などが
例示され、アシルオキシ基としてはホルミルオキシ基、
アセトキシ基、グロピオニルオキシ基等の低級アルキル
カルビニルオキシ基おヨヒペンゾイルオキシ基等のアリ
ールカルゲニルオキシ基などが例示される。Examples include hexyl group, heptyl group, octyl group, nonyl group, decyl group, dodecyl group, tridecyl group, octadecyl group, and nonadecyl group. Examples of the aralkyl group include benzyl group, 1-phenylethyl group, 2-phenylethyl group, and 3-phenylzolopyl group. X
represents an atom, a lower alkoxy group, an acyloxy group, a hydrogen sulfate group (H3O4-), or a hydroxyl group;
Examples of ron atoms include chlorine, bromine, and iodine, and examples of lower alkoxy groups include methoxy, ethoxy,
Examples include propoxy group, n-butoxy group, t-butoxy group, and examples of acyloxy group include formyloxy group,
Examples include lower alkylcarbinyloxy groups such as acetoxy group and glopionyloxy group, and arylcargenyloxy groups such as yohypenzoyloxy group.
一般式(3)で示される第4級アンモニウム塩の具体例
としては塩素化テトラエチルアンモニウム、臭素化テト
ラエチルアンモニウム、ヨウ素化テトラエテルアンモニ
ウム、塩素化テトラ−n−ブチルアンモニウム、臭素化
テトラ−n−ブチルアンモニウム、硫酸水素化テトラ−
n−ブチルアンモニウム、テトラ−n−ブチルアンモニ
ウムメトキシド、塩素化ペンノルトリメチルアンモニウ
ム、塩素化ステアリルトリメチルアンモニクムなどが挙
げられる。第4級アンモニウム塩の使用量は一般式(1
)で示されるハロスルホンおよび1または一般式(2)
で示されるビニルスルホンに対して0.1〜100 m
o1%、好ましくは、1〜5 mo1%の址である。Specific examples of the quaternary ammonium salt represented by the general formula (3) include chlorinated tetraethylammonium, brominated tetraethylammonium, iodinated tetraethylammonium, chlorinated tetra-n-butylammonium, and brominated tetra-n-butyl Ammonium, hydrogenated tetrasulfate
Examples include n-butylammonium, tetra-n-butylammonium methoxide, chlorinated pennortrimethylammonium, and chlorinated stearyltrimethylammonium. The amount of quaternary ammonium salt to be used is determined by the general formula (1
) and 1 or general formula (2)
0.1 to 100 m for vinyl sulfone shown in
o1%, preferably 1 to 5 mo1%.
またクラウンエーテルとしてはその環を形成する結合部
分に酸素原子、窒素原子および硫黄原子などの金属イオ
ンに対して配位能のある原子を合計で4個以上含有する
環状の、41Jエーテルであり、例えば12−クラウン
−4,15−クラウン−5,18−クラウン−6、ジペ
ンゾ−18−クラウン−6、ジシクロへキシル−18−
クラウン−6などがあげられる。クラウンエーテルの使
用量は一般式(1)で示されるノ・ロスルホンおよび/
または一般式(2)で示されるビニルスルホンに対して
0.1〜100 mo1%、好ましくは1〜10 mo
l’Jの量である。In addition, the crown ether is a cyclic 41J ether containing a total of 4 or more atoms capable of coordinating to metal ions such as oxygen atoms, nitrogen atoms, and sulfur atoms in the bonding portion forming the ring. For example, 12-crown-4,15-crown-5,18-crown-6, dipenzo-18-crown-6, dicyclohexyl-18-
Examples include Crown-6. The amount of crown ether used is determined by the amount of norosulfone and/or
or 0.1 to 100 mo1%, preferably 1 to 10 mo with respect to the vinyl sulfone represented by general formula (2)
It is the amount of l'J.
本発明に従う一般式(1)で示されるノ・ロスルホンお
よび/または一般式(2)で示めされるビニルスルホン
をビタミン人に誘導する反応は望ましくは不活性ガス雰
囲気下戻化水素系溶媒中で行なうことが必要であり、か
かる溶媒の例としてはトルエン、ベンゼン、ヘキサン、
シクロヘキサンナト751ffられる。溶媒の使用量は
、反応原料であるノ・ロスルホンおよび/lたは、ビニ
ルスルホンの濃度が約0.05〜2モル/lとなる程度
の量であることが好ましい。The reaction of inducing the vinyl sulfone represented by the general formula (1) and/or the vinyl sulfone represented by the general formula (2) according to the present invention to a vitamin compound is preferably carried out in an inert gas atmosphere and in a hydrogenated solvent. Examples of such solvents include toluene, benzene, hexane,
751ff of cyclohexanat. The amount of the solvent used is preferably such that the concentration of the reaction raw materials, rosulfone and vinyl sulfone, is about 0.05 to 2 mol/l.
本発明の方法により!y造されるビタミンAのカルメン
酸エステルとしては、例えば、ビタミン人アセテート、
ビタミンAノやルミテートなどが挙げられる。By the method of the present invention! Examples of the carmenic acid ester of vitamin A produced include vitamin acetate,
Examples include vitamin A and lumitate.
本反応は一10℃から100℃の温度範囲内で行なうこ
とができるが、0〜40℃の温度範吐が特に好ましい。This reaction can be carried out within a temperature range of -10°C to 100°C, but a temperature range of 0 to 40°C is particularly preferred.
本反応に使用する水酸化カリクムの使用tけノ・ロスル
ホン及び/またはビニルスルホンに対して好ましくは1
〜20モル倍址であり、さらに好ましくは5〜7モル倍
量である。反応終了後、反応混合物から必要に応じて沈
殿物を濾別したのち、該反応混合物に水、食塩水溶液な
どを加え、有機層を分離する。得られた有機層を再結晶
、カラムクロマトグラフィーなどの精製手段に付するこ
とによりビタミンAfc得るぐとができる。The amount of potassium hydroxide used in this reaction is preferably 1% per rosulfone and/or vinylsulfone.
The amount is 20 to 20 moles, more preferably 5 to 7 moles. After the reaction is completed, a precipitate is filtered from the reaction mixture as required, and then water, a saline solution, etc. are added to the reaction mixture, and the organic layer is separated. Vitamin Afc can be obtained by subjecting the obtained organic layer to purification means such as recrystallization and column chromatography.
このようにして得られたビタミンAを通常の方法により
アシル化することによりビタミン人のカルボン酸エステ
ルに誘導することができる。このアシル化反応は上記の
ビタミンAの生成反応によって得られた反応混合物から
分離されたビタミンAと含有する有機層又は該有機層か
ら分離絹製されたビタミンAに好適には有機溶媒中で第
3級アミン又はアルカリ金属炭酸塩の存在下にアシル化
剤を作用させることによシ行なわれる。アシル化剤とし
ては、例えば、無水酢酸、塩化アセチル、塩化lセルミ
ドイルなどが使用される。アシル化剤の使用量はビタミ
ンAに対して約1〜10当量が好ましい。有機溶媒とし
ては、例えば、ベンゼン、トルエンなどの炭化水素類;
塩化メチレン、1,2−ジクロルエタンなどのノ・ロダ
ン化炭化水素類;ゾエチルエーテル、ジイソゾロビルエ
ーテルなどのエーテル類:酢酸エチル、酢酸エチルなど
のエステル類などが使用され、これらの有機溶媒はビタ
ミン人の濃度が約0,1〜5モル/lとなる程度の量を
使用することが好ましい。第3級アミンとしては、例え
ば、トリエチルアミン、ピリシンなどが使用される。こ
れらの第3級アミンはビタミンAに対して約1〜10当
量用いることが好ましいが、さらに過剰量を用いること
によって該第3級アミンに有機溶媒としての役割を兼ね
させることもできる。アルカリ金属炭酸塩を用いる場合
は、たとえば炭酸ナトリウム、炭酸カリウム、炭酸リチ
ウムなどが使用され、その使用量はアシル化剤に対して
0.1〜5当量が好ましい。By acylating the vitamin A thus obtained by a conventional method, a carboxylic acid ester of vitamin A can be derived. This acylation reaction is performed on the vitamin A separated from the reaction mixture obtained by the above-mentioned vitamin A production reaction and the organic layer containing the vitamin A, or on the vitamin A separated from the organic layer, preferably in an organic solvent. This is carried out by using an acylating agent in the presence of a tertiary amine or an alkali metal carbonate. As the acylating agent, for example, acetic anhydride, acetyl chloride, cermidoyl chloride, etc. are used. The amount of the acylating agent used is preferably about 1 to 10 equivalents relative to vitamin A. Examples of organic solvents include hydrocarbons such as benzene and toluene;
Rhodanized hydrocarbons such as methylene chloride and 1,2-dichloroethane; ethers such as zoethyl ether and diisozorobyl ether; and esters such as ethyl acetate and ethyl acetate are used, and these organic solvents It is preferable to use an amount such that the concentration of vitamin A is about 0.1 to 5 mol/l. As the tertiary amine, for example, triethylamine, pyricine, etc. are used. These tertiary amines are preferably used in an amount of about 1 to 10 equivalents relative to vitamin A, but by using an excess amount, the tertiary amines can also serve as an organic solvent. When using an alkali metal carbonate, for example, sodium carbonate, potassium carbonate, lithium carbonate, etc. are used, and the amount used is preferably 0.1 to 5 equivalents based on the acylating agent.
反応は約−10℃〜50℃の温度範囲で行なうのが好適
である。反応終了後、反応混合物から必要に応じて沈殿
物を濾別したのち、該反応混合物に希硫酸、水、飽和炭
酸水素ナトリ゛ウム水溶液、水酸化ナトリウム水溶液な
どを加え、有機層を分離する。得られた有機層を再結晶
、カラムクロマトグラフィーなどの精製手段に付するこ
とによりビタミンAのカルがン酸エステルを得ることが
できる。Preferably, the reaction is carried out at a temperature range of about -10°C to 50°C. After the reaction is completed, the precipitate is filtered from the reaction mixture if necessary, and then dilute sulfuric acid, water, saturated aqueous sodium bicarbonate solution, aqueous sodium hydroxide solution, etc. are added to the reaction mixture, and the organic layer is separated. By subjecting the obtained organic layer to purification means such as recrystallization and column chromatography, vitamin A calcium ester can be obtained.
本発明において原料となるハロスルホンおよび/または
ビニルスルホンの合成法は、特開昭62−87559号
公報に記載の方法にしたがって製造される。すなわち、
−数式(5)
(式中、R1は、前記定義のとおりである)で示される
化合物と一般式(6)
(式中、R6は低級アシル基を表わす)で示される化合
物とをグリニヤ試薬、アルキルリチウムなどのアニオン
化剤の存在下で反応させることKより製造される一般式
(7)
(式中、R1およびR6は前記定義のとおりである)で
示されるヒドロキシスルホ/に塩化チオニル等のハログ
/化剤を作用させて一般式(8)(図中、R’ r R
’は前記定義のとおりであり XIはハロゲン原子を表
わす)
で示される化合物とし、これを水酸化ナトリウム、水酸
化カリウムなどの金属水酸化物で処理して−ff 式(
1)で示されるハロスルホンおよび一般式(2)で示さ
れる倦ビニルスルホンをそれぞれ選択的に製造すること
もできるし、これらを混合物として製造することもでき
る。本発明によればこれらのノ・ロスルホンおよびビニ
ルスルホ/からそれぞれ良好な収率でビタミンAへ導び
くことかできるし、またこれらの化合物を混合物として
用いてもよい収率でビタミンAへと導くことができる。The method for synthesizing halosulfone and/or vinylsulfone, which are raw materials in the present invention, is produced according to the method described in JP-A-62-87559. That is,
- a compound represented by formula (5) (wherein R1 is as defined above) and a compound represented by general formula (6) (wherein R6 represents a lower acyl group) using a Grignard reagent; Hydroxysulfo/thionyl chloride or the like represented by the general formula (7) (wherein R1 and R6 are as defined above) is produced by reacting K in the presence of an anionizing agent such as alkyl lithium. General formula (8) (in the figure, R' r R
' is as defined above;
The halosulfone represented by 1) and the vinyl sulfone represented by general formula (2) can be produced selectively, respectively, or they can be produced as a mixture. According to the present invention, it is possible to derive vitamin A from these rosulfone and vinyl sulfone in good yields, and it is also possible to derive vitamin A in good yields even when these compounds are used as a mixture. I can do it.
以下、実施例により本発明を説明するが、本発明はこれ
らの実施例により限定されるものではない。EXAMPLES The present invention will be explained below with reference to Examples, but the present invention is not limited to these Examples.
実施例1
窒素置換した2001R1フラスコに6−クロロ−1−
ヒドロキシ−3,7−ツメチルー9− (2,6,6−
ドリメチルー1−シクロヘキセン−1−イル)−9−7
エニルスルホニルー2.7−ノナゾェン9、29 fj
(20mmol )にトルエフ 40 atを入れ、
しばら〈攪拌したのち粉末状の水酸化カリウム(95%
純度) 5.89 jp (100mmol )と塩素
化テトラエチルアンモニウム66.319 (0,4m
mol )を加え、10℃で12時間攪拌した。反応液
に5チ食塩水50#Ilを加え分液した。この有機層に
無水酢酸1011(105,4mmol )及び炭酸ナ
トリウム0.99を加え、40℃で3時間攪拌した。1
0チの水酸化す) IJウム水溶液100 txlを反
応液に加えた後、有機層を分離し、さらにこの有機層を
5チ食塩水100m/で2回洗浄し、溶媒を留去するこ
とKより赤色の油状物12.8gを得九。この油状物を
高速液体クロマトグラフィーを用いて定量したところビ
タミンAアセテートの収率は80.9チであり、またビ
タミンAアセテート中の全トランス体比率は94.5チ
であった。Example 1 6-chloro-1- was added to a 2001R1 flask purged with nitrogen.
Hydroxy-3,7-tumethyl-9- (2,6,6-
Dolimethyl-1-cyclohexen-1-yl)-9-7
enylsulfonyl-2,7-nonazoene9,29 fj
(20 mmol), add Toluev 40 at,
After stirring for a while, powdered potassium hydroxide (95%
purity) 5.89 jp (100 mmol) and tetraethylammonium chloride 66.319 (0.4 m
mol) was added and stirred at 10°C for 12 hours. 50#Il of saline solution was added to the reaction solution to separate the layers. To this organic layer were added 1011 (105.4 mmol) of acetic anhydride and 0.99 of sodium carbonate, and the mixture was stirred at 40°C for 3 hours. 1
After adding 100 txl of IJum aqueous solution (100 txl of 0% hydroxide) to the reaction solution, separate the organic layer, wash this organic layer twice with 100ml of 5% brine, and distill off the solvent. 12.8 g of a redder oil was obtained. When this oily substance was quantified using high performance liquid chromatography, the yield of vitamin A acetate was 80.9%, and the total trans isomer ratio in vitamin A acetate was 94.5%.
実施例2
窒素置換した2 00 ytlフラスコに1−ヒドロキ
シ−3,7−ノメチルー9− (2,6,6−ドリメチ
ルー1−シクロヘキセン−1−イル)−9−フェニルス
ルホニル−2,6,8−ノナトリエン8.56g(20
mmol )にトルエン49m1を入れ、しばらく攪拌
したのち粉末状の水酸化カリウム(95%純度) 5.
89 g(Zoo mmol )と塩素化テトラエチル
アンモニウム66.3 W (0,4mmol )を加
え10℃で12時間攪拌した。反応液に5%食塩水50
IIllを加え分液した。この有機層に無水酢酸101
11(105,4mmol )及び炭酸ナトリウム0.
9gを加え、40℃で3時間攪拌した。10%の水酸化
ナトリウム水溶液100mjを反応液に加えた後、有機
層を分離し、さらにこの有機層を5チ食塩水100nj
で2回洗浄し、溶媒を留去することによυ赤色の油状物
12.69を得た。この油状物を高速液体クロマトグラ
フィーを用いて定量したところビタミンAアセテートの
収率は78.9チであシ。Example 2 1-Hydroxy-3,7-nomethyl-9-(2,6,6-drimethyl-1-cyclohexen-1-yl)-9-phenylsulfonyl-2,6,8- was placed in a 200 ytl flask purged with nitrogen. Nonatriene 8.56g (20
5. Add 49 ml of toluene (mmol) and stir for a while, then add powdered potassium hydroxide (95% purity).
89 g (Zoo mmol) and 66.3 W (0.4 mmol) of chlorinated tetraethylammonium were added and stirred at 10° C. for 12 hours. Add 5% saline to the reaction solution
IIll was added and the mixture was separated. Add 101 ml of acetic anhydride to this organic layer.
11 (105.4 mmol) and sodium carbonate 0.
9 g was added and stirred at 40°C for 3 hours. After adding 100 mj of a 10% aqueous sodium hydroxide solution to the reaction solution, the organic layer was separated, and this organic layer was further diluted with 100 mj of brine.
By washing twice with When this oily substance was quantified using high performance liquid chromatography, the yield of vitamin A acetate was 78.9%.
またビタミンAアセテート中の全トランス体比率は94
.3%であった。In addition, the total trans isomer ratio in vitamin A acetate is 94.
.. It was 3%.
実施例3
窒素置換した2 00 atフラスコに6−りoo−ヒ
ドロキシ−3,7−ノメチルー9− (2,6,6−ト
リメチル−l−シクロヘキセン−1−イル)−9−7エ
ニルスルホニルー2,7−ノナジェン2.6g(5,6
mmol )と1−ヒドロキシ−3,7−ノメチルー
9− (2,6,6−)ジメチル−1−フクロヘキセン
−1−イル)−9−フェニルスルホニル−2,6,8−
ノナトルエン6.169 (14,4mmol )の混
合物にトルエン4 Q mlを入れ、しばらく攪拌した
のち粉末状の水酸化゛カリウム(95%純度)5.89
,9(100mmol )と塩素化テトラエチルアンモ
ニウム66.3 ”? (0,4mmol )を加え、
10℃で12時間攪拌した。反応液に5チ食塩水5Q*
lを加え分液した。この有機層に無水酢酸10R1(1
05,4mmol)及び炭酸ナトリウム0.9gを加え
、40℃で3時間攪拌した。10%の水酸化す) IJ
ウム水溶液1001を反応液に加えた後、有機層を分離
し、さらにこの有機層を5チ食塩水100t/で2回洗
浄し、溶媒を留去することにより赤色の油状物12.3
gを得た。この油状物を高速液体クロマトグラフィーを
用いて定量したとこうビタミンAアセテートの収率は7
7.9チであり、またビタミンAアセテート中の全トラ
ンス体比率は94.5%であった。Example 3 6-rioo-hydroxy-3,7-nomethyl-9-(2,6,6-trimethyl-l-cyclohexen-1-yl)-9-7enylsulfonyl-2 was added to a 200 at flask purged with nitrogen. , 7-nonadiene 2.6 g (5,6
mmol) and 1-hydroxy-3,7-nomethyl-
9-(2,6,6-)dimethyl-1-fuclohexen-1-yl)-9-phenylsulfonyl-2,6,8-
4 Q ml of toluene was added to a mixture of 6.169 (14.4 mmol) of nonatoluene, and after stirring for a while, powdered potassium hydroxide (95% purity) 5.89
, 9 (100 mmol) and chlorinated tetraethylammonium 66.3"? (0.4 mmol),
The mixture was stirred at 10°C for 12 hours. Add 5Q salt solution to the reaction solution 5Q*
1 was added and the liquid was separated. This organic layer was added with acetic anhydride 10R1 (1
05.4 mmol) and 0.9 g of sodium carbonate were added, and the mixture was stirred at 40°C for 3 hours. 10% hydroxide) IJ
After adding 1,001 g of aqueous solution of 1,001 g of umum to the reaction solution, the organic layer was separated, and this organic layer was further washed twice with 100 tons of brine, and the solvent was distilled off to obtain a red oily substance 12.3
I got g. When this oily substance was quantified using high performance liquid chromatography, the yield of vitamin A acetate was 7.
7.9%, and the total trans isomer ratio in vitamin A acetate was 94.5%.
実施例4
窒素置換した200ゴフラスコに6−クロロ−1−ヒド
ロキシ−3,7−ノメチルー9− (2,6,6−ドリ
メチルー1−シクロヘキセン−1−イル)−9−フェニ
ルスルホニル−2,7−ノナ・ジエン2、69 (5,
6mmol )と1−ヒドロキシ−3,7−ノメチルー
9− (2,6,6−)ジメチル−1−シクロヘキセン
−1−イル)−9−フェニルスルホニル−2,6,8−
ノナトリエン6、16 、lil (14,4mmol
)ノ混合物にトルエン40m1を入れしばらく攪拌し
たのち、粉末状の水酸化カリウム(95チ純度)5.8
9 g(100mmol )と12−クラウン−471
89(0,4mmol )を加え、10℃で12時間攪
拌した。反応液に5−食塩水501Ltを加え分液した
。この有機層に無水酢酸10 d (105,4mmo
l )及び炭酸ナトリウム0.9gを加え、40℃で3
時間攪拌した。10%の水酸化ナトリクム水溶液100
mtを反応液に加えた後、有機層を分離し、さらにこの
有機層を5チ食塩水100R1で2回洗浄し、溶媒を留
去することにより、赤色の油秋物13、19を得た。こ
の油状物を高速液体クロマトグラフィーを用いて定量し
たところビタミンA7セテートの収率は78.2チであ
り、またビタミンAアセテート中の全トランス体比率は
93.8%であった0
〔発明の効果〕
本発明の方法によれば上記の実施例から明らかなとおシ
安価にかつ容易に入手できる工業原料から好収率でかつ
容易にビタミン人、さらにはそのアセテートを製造する
ことができる。Example 4 6-chloro-1-hydroxy-3,7-nomethyl-9-(2,6,6-drimethyl-1-cyclohexen-1-yl)-9-phenylsulfonyl-2,7- was placed in a 200-gof flask purged with nitrogen. Nona Jien 2, 69 (5,
6 mmol) and 1-hydroxy-3,7-nomethyl-9-(2,6,6-)dimethyl-1-cyclohexen-1-yl)-9-phenylsulfonyl-2,6,8-
nonatriene 6,16, lil (14,4 mmol
) Add 40 ml of toluene to the mixture and stir for a while, then add powdered potassium hydroxide (95% purity) 5.8
9 g (100 mmol) and 12-crown-471
89 (0.4 mmol) was added and stirred at 10°C for 12 hours. 501 Lt of 5-saline solution was added to the reaction solution and the mixture was separated. To this organic layer was added 10 d of acetic anhydride (105,4 mmo
l) and 0.9 g of sodium carbonate, and heated at 40°C.
Stir for hours. 10% sodium hydroxide aqueous solution 100
After mt was added to the reaction solution, the organic layer was separated, and this organic layer was further washed twice with 100 R1 of 5-chloride solution, and the solvent was distilled off to obtain red oil-filled products 13 and 19. When this oil was quantified using high performance liquid chromatography, the yield of vitamin A7 acetate was 78.2%, and the total trans isomer ratio in vitamin A acetate was 93.8%. [Effects] According to the method of the present invention, as is clear from the above examples, vitamins and their acetates can be easily produced in good yield from industrial raw materials that are inexpensive and easily available.
特許出願人 株式会社 り ラ しPatent applicant: RiRashi Co., Ltd.
Claims (1)
わし、X^1はハロゲン原子を表わす) で示されるハロスルホンおよび/または一般式(2)▲
数式、化学式、表等があります▼(2) (式中、R^1は前記定義のとおりである)で示される
ビニルスルホンを炭化水素系溶媒中、一般式(3) ▲数式、化学式、表等があります▼(3) (式中、R^2、R^3、R^4およびR^5は同一ま
たは異なりそれぞれアルキル基もしくはアラルキル基で
あり、Xはハロゲン原子、低級アルコキシ基、アシルオ
キシ基、硫酸水素基又は水酸基を表わす)で示される第
4級アンモニウム塩又はクラウンエーテルの存在下水酸
化カリウムで処理し、必要に応じて生成するビタミンA
をアシル化することを特徴とするビタミンA又はそのカ
ルボン酸エステルの製法。[Claims] General formula (1) ▲Mathematical formulas, chemical formulas, tables, etc.▼(1) (In the formula, R^1 represents an optionally substituted phenyl group, and X^1 represents a halogen atom. ) Halosulfone and/or general formula (2) ▲
There are mathematical formulas, chemical formulas, tables, etc. ▼ (2) (In the formula, R^1 is as defined above) In a hydrocarbon solvent, general formula (3) ▲ Mathematical formulas, chemical formulas, tables etc. ▼(3) (In the formula, R^2, R^3, R^4 and R^5 are the same or different and are each an alkyl group or an aralkyl group, and X is a halogen atom, a lower alkoxy group, an acyloxy group , representing a hydrogen sulfate group or a hydroxyl group) or a crown ether (representing a hydrogen sulfate group or a hydroxyl group).
A method for producing vitamin A or its carboxylic acid ester, which comprises acylating vitamin A or its carboxylic acid ester.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16819188A JPH0611753B2 (en) | 1988-07-05 | 1988-07-05 | Vitamin A manufacturing method |
US07/368,800 US4942262A (en) | 1988-07-05 | 1989-06-20 | Process for producing vitamin A or its carboxylic acid esters |
DE68915213T DE68915213T2 (en) | 1988-07-05 | 1989-07-04 | Process for the preparation of vitamin A or its carboxylic acid esters. |
EP89112218A EP0349991B1 (en) | 1988-07-05 | 1989-07-04 | Process for producing vitamin A or its carboxylic acid esters |
DK331189A DK170160B1 (en) | 1988-07-05 | 1989-07-04 | Process for the preparation of vitamin A or its carboxylic acid esters |
FI893252A FI90068C (en) | 1988-07-05 | 1989-07-04 | FRUIT PROCESSING FOR A VITAMIN A ELLER DESS CARBOXYLSYRAESTRAR |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16819188A JPH0611753B2 (en) | 1988-07-05 | 1988-07-05 | Vitamin A manufacturing method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0217173A true JPH0217173A (en) | 1990-01-22 |
JPH0611753B2 JPH0611753B2 (en) | 1994-02-16 |
Family
ID=15863472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16819188A Expired - Fee Related JPH0611753B2 (en) | 1988-07-05 | 1988-07-05 | Vitamin A manufacturing method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0611753B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009230368A (en) * | 2008-03-21 | 2009-10-08 | Brother Ind Ltd | Sentence creation condition specifying method, sentence creation condition specifying device, and sentence creation condition specifying program |
-
1988
- 1988-07-05 JP JP16819188A patent/JPH0611753B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009230368A (en) * | 2008-03-21 | 2009-10-08 | Brother Ind Ltd | Sentence creation condition specifying method, sentence creation condition specifying device, and sentence creation condition specifying program |
Also Published As
Publication number | Publication date |
---|---|
JPH0611753B2 (en) | 1994-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | Radical-mediated synthesis of trifluoroethyl amines and trifluoromethyl ketones from alkyl iodides | |
JPH0217173A (en) | Production of vitamin a or carboxylic acid ester thereof | |
CN111004176A (en) | Synthesis method of 2-aryloxy ethanol compound | |
JPH0211559A (en) | Production of disulfide | |
JP7217971B2 (en) | Sulfonylazidobenzoic acid derivatives and their reactive derivatives | |
US4942262A (en) | Process for producing vitamin A or its carboxylic acid esters | |
JPS6220995B2 (en) | ||
US5310926A (en) | Process for producing isoxazole derivatives | |
JPH0611752B2 (en) | Vitamin A manufacturing method | |
EP0464218B1 (en) | Process for producing isoxazole derivative | |
JP6434261B2 (en) | Iodobenzamide type alcohol oxidation catalyst | |
JPS6019312B2 (en) | Method for producing oxazolinoazetidinylpentenoic acid derivatives | |
JP2020142996A (en) | Method for manufacturing aryl fluorene derivatives | |
JP2004107207A (en) | Method for producing hotrienol and its ester | |
JPH0611751B2 (en) | Method for producing vitamin A | |
JP2003335728A (en) | Method for producing 4-methylcyclopentenone derivative | |
JP2007145821A (en) | Method for producing 4-hydroxy-2-adamantanone compound | |
JPS6254303B2 (en) | ||
JPH07252183A (en) | Production of phenol derivative | |
JP2000044571A (en) | Production of 13-ester derivatives of milbemycin compounds | |
JP2018108942A (en) | Method for producing alkali salt of acetoacetic ester and method for producing aliphatic diketone | |
JP2000198775A (en) | Cyclic guanidine and its production | |
JPH07285913A (en) | Production of 3-acyloxy-2,3-unsaturated ketones | |
JPH078827B2 (en) | Method for producing α, β-unsaturated aldehyde | |
JPS5914014B2 (en) | Production method of hydroquinone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |